E72.4

Clinical Causes: Genetic mutations affecting enzymes involved in the urea cycle, such as ornithine transcarbamylase. Inherited metabolic disorders passed down through family lines. Deficiencies or dysfunctions in specific enzymes or transporters regulating ornithine and related metabolites. Rare cases may involve acquired factors impacting enzyme activity, though most are genetic.

Key Symptoms: Elevated levels of ammonia in the blood (hyperammonemia), leading to neurological symptoms. Vomiting and poor feeding, especially in infants. Lethargy, confusion, or irritability. Seizures or coma in severe cases. Hyperornithinemia, which may be detected through blood tests. In some types, characteristic biochemical features such as increased homocitrulline levels.

Diagnosis Path: Diagnosis involves a combination of biochemical tests and genetic analysis. Key steps include: - Blood tests to measure ammonia, ornithine, and other amino acids. - Urine testing for metabolites like homocitrulline. - Enzyme activity assays, if applicable. - Genetic testing to identify mutations in relevant genes, such as OTC. Early detection through newborn screening programs can facilitate prompt intervention.

Treatment Protocols: Management strategies focus on reducing ammonia levels and preventing metabolic crises. Common approaches include: - Dietary restrictions on protein intake to decrease ammonia production. - Medications such as ammonia scavengers (e.g., sodium benzoate) to help eliminate excess ammonia. - Supplementation with specific amino acids like arginine. - In acute episodes, interventions like dialysis may be necessary to rapidly remove toxins. - Long-term monitoring and regular follow-up with specialists to adjust dietary plans and medications. Emerging therapies and gene therapy are areas of ongoing research.